Atlas Genetics, a British molecular diagnostics startup that creates rapid point-of-care tests for infectious diseases like chlamydia, will launch U.S. clinical trials with a $20 million Series C ...
If the COVID-19 pandemic taught us anything, it’s the value of testing for infection at home without the need to visit a health facility. Now a series of studies have found that testing for sexually ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback